Nasdaq · CIK 0001951222
LAES SEALSQ Corp
Insider trading from SEC Form 4. Last filing 5 d ago. Close $2.11 on Oct 9, 2026, +1% from the 52-week low and -72% from the high.
Last 90 days
Net insider value
-$122k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$122k by 1 insider
Insiders on file
5
with a Form 4 at this company
Price and insider trades, last year
LAESOct 9, 2026 · close 2.11
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at SEALSQ Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 9Weak | Jean-Pierre Enguent Vice President, R&DSS sell | $86k 35,000 shares | -100% | +16% from low-68% from high | |
| 6Weak | Jean-Pierre Enguent Vice President, R&DSS sell | $36k 15,000 shares | -100% | - |
Transactions
The last 15 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Jean-Pierre Enguent Vice President, R&DSS | MOption exercise Ordinary Shares10b5-1 | +35,000 | $0.01 | $350 | 35,000 | 5 d ago |
| Oct 6, 2026 | Jean-Pierre Enguent Vice President, R&DSS | SOpen-market sale Ordinary Shares10b5-1 | -35,000 | $2.46 | $86k | 0 | 5 d ago |
| Oct 5, 2026 | Jean-Pierre Enguent Vice President, R&DSS | AGrant or award Employee Stock Option Plan (right to buy)derivative10b5-1 | +50,000 | $0.00 | $0 | 50,000 | 5 d ago |
| Oct 5, 2026 | Jean-Pierre Enguent Vice President, R&DSS | MOption exercise Employee Stock Option Plan (right to buy)derivative10b5-1 | -35,000 | $0.00 | $0 | 15,000 | 5 d ago |
| Oct 5, 2026 | Peter Ward director | AGrant or award Employee Stock Option Plan (right to buy)derivative | +3,582 | $0.00 | $0 | 3,582 | 6 d ago |
| Sep 25, 2026 | David Alexander Fergusson director | AGrant or award Employee Stock Option Plan (right to buy)derivative | +3,424 | $0.00 | $0 | 3,424 | 6 d ago |
| Sep 25, 2026 | Eric Adrien Pellaton director | AGrant or award Employee Stock Option Plan (right to buy)derivative | +10,747 | $0.00 | $0 | 10,747 | 6 d ago |
| Oct 5, 2026 | Peter Ward director | AGrant or award Employee Stock Option Plan (right to buy)derivative | +4,686 | $0.00 | $0 | 4,686 | 6 d ago |
| Sep 25, 2026 | David Alexander Fergusson director | AGrant or award Employee Stock Option Plan (right to buy)derivative | +14,063 | $0.00 | $0 | 14,063 | 6 d ago |
| Sep 25, 2026 | Eric Adrien Pellaton director | AGrant or award Employee Stock Option Plan (right to buy)derivative | +14,063 | $0.00 | $0 | 14,063 | 6 d ago |
| Sep 1, 2026 | Jean-Pierre Enguent Vice President, R&DSS | MOption exercise Ordinary Shares10b5-1 | +15,000 | $0.01 | $150 | 15,000 | 39 d ago |
| Sep 3, 2026 | Jean-Pierre Enguent Vice President, R&DSS | SOpen-market sale Ordinary Shares10b5-1 | -15,000 | $2.40 | $36k | 0 | 39 d ago |
| Sep 1, 2026 | Jean-Pierre Enguent Vice President, R&DSS | MOption exercise Employee Stock Option Plan (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 0 | 39 d ago |
| Mar 27, 2026 | Franck Jean Buonanno Vice-President, Global Sales | MOption exercise Ordinary Shares | +15,000 | $0.01 | $150 | 20,000 | Mar 27, 2026 |
| Mar 27, 2026 | Franck Jean Buonanno Vice-President, Global Sales | MOption exercise Employee Stock Option (right to buy)derivative | -15,000 | $0.00 | $0 | 20,000 | Mar 27, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Franck Jean BuonannoVice-President, Global Sales
- Jean-Pierre EnguentVice President, R&DSS
- David Alexander Fergussondirector
- Eric Adrien Pellatondirector
- Peter Warddirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.